Williams SD - Search Results

1

Prediction of the need for red cell transfusion in newly diagnosed ovarian cancer patients undergoing platinum-based treatment.

Heddens D, Alberts DS, Hannigan EV, Williams SD, Garcia D, Roe DJ, Bell J, Alvarez RD. Heddens D, et al. Among authors: williams sd. Gynecol Oncol. 2002 Sep;86(3):239-43. doi: 10.1006/gyno.2002.6726. Gynecol Oncol. 2002. PMID: 12217742

2

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

Alberts DS, Liu PY, Hannigan EV, O'Toole R, Williams SD, Young JA, Franklin EW, Clarke-Pearson DL, Malviya VK, DuBeshter B. Alberts DS, et al. Among authors: williams sd. N Engl J Med. 1996 Dec 26;335(26):1950-5. doi: 10.1056/NEJM199612263352603. N Engl J Med. 1996. PMID: 8960474 Free article. Clinical Trial.

3

Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group.

Williams SD, Kauderer J, Burnett AF, Lentz SS, Aghajanian C, Armstrong DK. Williams SD, et al. Gynecol Oncol. 2004 Dec;95(3):496-9. doi: 10.1016/j.ygyno.2004.07.044. Gynecol Oncol. 2004. PMID: 15581952 Clinical Trial.

4

Salvage therapy for recurrent and refractory ovarian cancer with high-dose chemotherapy and autologous bone marrow support: a Gynecologic Oncology Group pilot study.

Broun ER, Belinson JL, Berek JS, McIntosh D, Hurd D, Ball H, Williams S. Broun ER, et al. Gynecol Oncol. 1994 Aug;54(2):142-6. doi: 10.1006/gyno.1994.1183. Gynecol Oncol. 1994. PMID: 8063237 Clinical Trial.

5

Late relapse of ovarian dysgerminoma: case report and literature review.

Bekaii-Saab T, Einhorn LH, Williams SD. Bekaii-Saab T, et al. Among authors: williams sd. Gynecol Oncol. 1999 Jan;72(1):111-2. doi: 10.1006/gyno.1998.5207. Gynecol Oncol. 1999. PMID: 9889041 Review.

6

Ovarian germ cell tumors: an update.

Williams SD. Williams SD. Semin Oncol. 1998 Jun;25(3):407-13. Semin Oncol. 1998. PMID: 9633853 Review.

7

Second-look laparotomy in ovarian germ cell tumors: the gynecologic oncology group experience.

Williams SD, Blessing JA, DiSaia PJ, Major FJ, Ball HG 3rd, Liao SY. Williams SD, et al. Gynecol Oncol. 1994 Mar;52(3):287-91. doi: 10.1006/gyno.1994.1050. Gynecol Oncol. 1994. PMID: 8157184

8

Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group Study.

Gershenson DM, Miller AM, Champion VL, Monahan PO, Zhao Q, Cella D, Williams SD; Gynecologic Oncology Group. Gershenson DM, et al. Among authors: williams sd. J Clin Oncol. 2007 Jul 1;25(19):2792-7. doi: 10.1200/JCO.2006.08.4590. J Clin Oncol. 2007. PMID: 17602084

9

Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group.

Williams S, Blessing JA, Liao SY, Ball H, Hanjani P. Williams S, et al. J Clin Oncol. 1994 Apr;12(4):701-6. doi: 10.1200/JCO.1994.12.4.701. J Clin Oncol. 1994. PMID: 7512129 Clinical Trial.

10

Chemotherapy of ovarian cancer: is longer better?

Williams SD. Williams SD. Gynecol Oncol. 1992 Oct;47(1):5-6. doi: 10.1016/0090-8258(92)90066-r. Gynecol Oncol. 1992. PMID: 1427401 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

292 results

Search Page

Filters